Molecular Therapy: Methods & Clinical Development (Jan 2016)

An HSV-based library screen identifies PP1α as a negative TRPV1 regulator with analgesic activity in models of pain

  • Bonnie Reinhart,
  • William F Goins,
  • Asaff Harel,
  • Suchita Chaudhry,
  • James R Goss,
  • Naoki Yoshimura,
  • William C de Groat,
  • Justus B Cohen,
  • Joseph C Glorioso

DOI
https://doi.org/10.1038/mtm.2016.40
Journal volume & issue
Vol. 3, no. C

Abstract

Read online

Transient receptor potential vanilloid 1 (TRPV1) is a pronociceptive cation channel involved in persistent inflammatory and neuropathic pain. Herpes simplex virus (HSV) vector expression of TRPV1 causes cell death in the presence of capsaicin, thereby completely blocking virus replication. Here we describe a selection system for negative regulators of TRPV1 based on rescue of virus replication. HSV-based coexpression of TRPV1 and a PC12 cell-derived cDNA library identified protein phosphatase 1α (PP1α) as a negative regulator of TRPV1, mimicking the activity of “poreless” (PL), a dominant-negative mutant of TRPV1. Vectors expressing PP1α or PL reduced thermal sensitivity following virus injection into rat footpads, but failed to reduce the nocifensive responses to menthol/icilin-activated cold pain or formalin, demonstrating that the activity identified in vitro is functional in vivo with a degree of specificity. This system should prove powerful for identifying other cellular factors that can inhibit ion channel activity.